Nov 3rd, 2025
Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal
Kimberly-Clark agreed to buy Kenvue in a deal worth roughly $40 billion in a combination that could create a company with $32 billion in revenue and allow it to surpass Unilever to become the second-biggest seller of health and wellness products after Procter & Gamble. Eric Pfanner reports on Bloomberg Television.
